MedPath
HSA Approval

JUBITEL 40 TABLET 40MG

SIN15447P

JUBITEL 40 TABLET 40MG

JUBITEL 40 TABLET 40MG

March 13, 2018

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09CA07

telmisartan

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

Jubilant Generics Limited

Active Ingredients

Telmisartan

40mg

Telmisartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JUBITEL 40 TABLET 40MG - HSA Approval | MedPath